Cargando…

Volumetric Arc Therapy Treatment Plan Dosimetry Correction Method to Account Patient Weight Loss during a Course of Radiation Therapy

AIM: This study aims to validate volumetric arc therapy (VMAT) plan correction method for a patient's lost weight during the course of radiotherapy. MATERIALS AND METHODS: VMAT plans of prostate and head and neck cancers were considered to evaluate dosimetric effects due to external surface cha...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Harold, Weatherburn, Henry, Dwivedi, Abhishek, Ganesh, Tharmarnadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185707/
https://www.ncbi.nlm.nih.gov/pubmed/32355429
http://dx.doi.org/10.4103/jmp.JMP_86_19
Descripción
Sumario:AIM: This study aims to validate volumetric arc therapy (VMAT) plan correction method for a patient's lost weight during the course of radiotherapy. MATERIALS AND METHODS: VMAT plans of prostate and head and neck cancers were considered to evaluate dosimetric effects due to external surface changes caused by patient's weight loss during treatment. Accepted VMAT treatment plan was recalculated on the planning computed tomography (CT) with a newly created external contour from cone-beam CT and was compared with the original plan. Monitor unit (MU) correction was applied based on a simple formalism, and doses were recalculated. Dose statistics were compared with the original plan. Ten patients with significant weight loss were considered to validate proposed MU correction method by comparing the dose statistics before and after MU corrections. RESULTS: We observed 3.7%–5.2% change in the plan maximum dose for one cm change in path length to isocenter with increased planning target volume dose, D95 by 4%. The organs at risk (OAR) doses increased as high as 6.8%. Using MU correction method, target volume and OARs dose changes were reduced to <1% when compared with the original plan. The correction method brought down the maximum plan dose and volume of 95% isodose (V95) cloud below an acceptable range of 1%–2% in 10 patients treatment plans. CONCLUSION: Image-guided radiation therapy process detects the weight loss, which affects the treatment plan's dose distribution and should be corrected. Applying the correction method described here keeps the patient dosimetry within 1% of the original plan, which is clinically acceptable. The process of plan dosimetry correction to address weight loss can be completed within 30 min without repeating imaging and planning process.